On September 3, Yuheng Pharmaceutical said during an investigation at the reception agency that mergers and acquisitions are one of the important ways for the company to obtain products. The company pays more attention to the value of the underlying assets and synergy with the company, and does not set limits on the path to obtain the product. The company will combine the market and its own reality to select suitable mergers and acquisitions targets. The company will focus on the pharmaceutical circuit, not considering the medical field.

Disclaimer:Webull uses external vendor Google Translation Service for news translations where we endeavour to ensure these are correct, however, we recommend that you please double-check this information accordingly. Webull is not responsible for translation errors or issues.